Clostridium difficile infections in China

Journal of Biomedical Research

Volumn 24, Issue 6, 2010, Pages 411-416

  Jin, Ke ^a   Wang, Shixia ^a,b   Huang, Zuhu ^a   Lu, Shan ^a,b  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Clostridium difficile; Incidence; Prevalence; Review; Risk factors

Indexed keywords

AMINOGLYCOSIDE; AMPICILLIN; C REACTIVE PROTEIN; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; COPTIS CHINENSIS EXTRACT; ERYTHROMYCIN; GARLIC EXTRACT; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PROBIOTIC AGENT; PROTON PUMP INHIBITOR; RIFAMPICIN; SCUTELLARIAE RADIX; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACILLUS LICHENIFORMIS; BACTERIAL STRAIN; CHINA; CLOSTRIDIUM BUTYRICUM; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; DIARRHEA; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDEMIC DISEASE; GASTROINTESTINAL DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL INFECTION; HUMAN; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSEUDOMEMBRANOUS COLITIS; RECURRENCE RISK; RESPIRATORY TRACT INTUBATION; REVIEW; RISK FACTOR; STOMACH INTUBATION;

EID: 78650647759     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(10)60055-3     Document Type: Review

References (38)

1. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tull P, Gastmeier P, et al. Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect 2008, 14(Suppl 5):2-20.
2. Mutters R, Nonnenmacher C, Susin C, Albrecht U, Kropatsch R, Schumacher S Quantitative detection of Clostridium difficile in hospital environmental samples by real-time polymerase chain reaction. J Hosp Infect 2009, 71:43-48.
3. Dubberke ER, Reske KA, Noble-Wang J, Thompson A, Killgore G, Mayfield J, et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007, 35:315-318.
4. Huang H, Wu S, Wang M, Zhang Y, Fang H, Palm-gren AC, et al. Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China. Clin Infect Dis 2008, 47:1606-1608.
5. Huang H, Weintraub A, Fang H, Nord CE Antimicrobial resistance in Clostridium difficile. Int J Antimicrob Agents 2009, 34:516-522.
6. McDonald LC, Owings M, Jernigan DB Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006, 12:409-415.
7. Dubberke ER, Butler AM, Yokoe DS, Mayer J, Hota B, Mangino JE, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol 2010, 31:1030-1037.
8. Kotila S, Virolainen A, Snellman M, Ibrahem S, Jalava J, O. L. Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008. Clin Microbiol Infect 2010; doI: 10. 1111/j. 1469-0691. 2010.03384. x. [Epub ahead of print].
9. Hensgens M, Goorhuis A, Notermans D, van Benthem B, Kuijper E Changing epidemiology of infections in the Netherlands in 2008/'09. Ned Tijdschr Geneeskd 2010, 154:1317.
10. Chen DM, Chen QG, Chen JX 21 cases of Clostridium difficile colitis. Guangdong Medical J (in Chinese) 2000, 21:519.
11. Wang W, Liu X Clinical analysis of 36 cases of Clostridium difficile colitis. Chin J Medicine (in Chinese) 2004, 39:32-33.
12. Yang YH, Zhang CP, Cai H Investigation on the causes of intestinal bacterial flora imbalance and treatment of drug-resistant. Chin J Nosocomiol (in Chinese) 2006, 16(1):83-85.
13. Du RL Clinical study on chemotherapy-induced diarrhea. Inner Mongolia Med J (in Chinese) 2007, 39:158-160.
14. Chen C, Qiu L The study enteroflora and treatment of digestive tracty chemotherapy-induced diarrhea. Chin J Clin Gastroenterol (in Chinese) 2006, 18:89-90.
15. Jiang Z, Qiu L, Zhu X Clinical research on norvanco-mycin treatment of chemotherapy-related diarrhea. Chin J Intern Med (in Chinese) 2003, 42:869-870.
16. Gerding DN Global epidemiology of Clostridium difficile infection in 2010. Infect Control Hosp Epidemiol 2010, 31(Suppl 1):S32-S34.
17. Huang H, Fang H, Weintraub A, Nord CE Distinct ri-botypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm. Clin Microbiol Infect 2009, 15:1170-1173.
18. Huang H, Weintraub A, Fang H, Nord CE Comparison of a commercial multiplex real-time PCR to the cell cy-totoxicity neutralization assay for diagnosis of clostrid-ium difficile infections. J Clin Microbiol 2009, 47:3729-3731.
19. Huang H, Weintraub A, Fang H, Nord CE Community acquired Clostridium difficile infection due to a moxi-floxacin susceptible ribotype 027 strain. Scand J Infect Dis 2009, 41:158-159.
20. Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, et al. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ri-botypes. Int J Antimicrob Agents 2009, 33:339-342.
21. Yang Y, Zhang J, Cai H Intestinal tract dysbacterio-sis: causes, drug resistance and treatment investigation. Chin J Nosocomiol (in Chinese) 2006, 16:83-85.
22. Chen W, Jin G, Liu Y Report of Clostridium difficile infection in elderly patients in neurological department. Military Med J South China (in Chinese) 2001, 15:13-15.
23. Liu X, Song J, Zhang X Antibiotic-associated diarrhea in post-operative neurosurgical patients: clinical features, diagnosis and treatment of 36 cases. Chin J Mod Med (in Chinese) 2006, 16:1235-1241.
24. Jia JS, Huang XJ, Liu DH, Xiu LP, Zhang YC, Wu T, et al. Relationship between Clostridium difficile associated diarrhea and intestinal microecosystem disorder in patients received allogeneic hematopoietic stem cell transplantation. J Exp Hematol 2008, 16:135-139.
25. Cai X, Lu D, SQ C Changes of pathogens and antibiotic sensitivity in children with persistent and chronic diarrheal disease during a decade. Clin Med of China (in Chinese) 2001, 17:634-635.
26. Wang Y Integrated treatment of 72 cases with antibiotic-associated colitis. Chin J Integrative Med (in Chinese) 2003, 23:586.
27. Huang Y, Nie Y Clinic epidemic comparisons of Clostridium difficile-associated diarrhea with antibiotic-associated diarrhea. J Guangdong Med Coll (in Chinese) 2009, 27:373-375.
28. Kuijper E, Barbut F, Brazier J Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill 2008, 13:18492.
29. Chen W, Jin G, Liu YY Report on hospital outbreaks of Clostridium difficile infection in hospitalized elderly patients. Chin J Nosocomiol (in Chinese) 2001, 11:23-24.
30. Cheng Y, Lu J, Yan S Primary study on the gene typing, molecular characteristics of virulence and resistance associated gene of 12 Clostridium difficile clinical isolates in China. Chin J Zoonoses (in Chinese) 2009, 25:401-405.
31. Cheng Y, Lu JX, Yan SK, Jia HB, Li WG Study on toxin characteristics of Clostridium difficile isolated from hospital. Dis Surv (in Chinese) 2009, 24:193-195.
32. Cheng Y, Lu J, Yan S Study on drug resistance of Clostridium difficile isolated from hospital. Dis Surv (in Chinese) 2009, 24:346-348.
33. Cao Y, Zhang X, Pan LJ The clinical research between Clostridium difficile colonitis and intestinal microeco-system. Chin J Mod Med (in Chinese) 2002, 12:47-51.
34. Xu X, Yang Z Report on the treatment of Live Bacillus Licheniformis preparation Dral in 10 cases with pseu-domembranous colitis after abdominal surgery. J Qiqi-har Med Coll (in Chinese) 2001, 22:1027.
35. Wei H, Wang K Observation of high-dose intravenous gamma globulin treatment in children with antibiotic associated diarrhea. Med J Qilu (in Chinese) 2002, 17:234.
36. Luan X, Wang J, Yang X Clinical analysis in 28 patients with clostridium difficile colitis. J Taishan Med Coll (in Chinese) 2004, 25:295-296.
37. He S, Yuan H Integrated treatment of 60 cases with Pseudomembranous colitis. Guangxi J Trad Chin Med (in Chinese) 2006, 29:22-23.
38. Dai T Garlic preparations as an adjuvant of antipyretic dryingdampness agents for the treatment of Pseu-domembranous Colitis. J Hubei Univ Chin Med (in Chinese) 2010, 12.